Atrial Fibrillation History Feature vs Strain AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Exo

AI Verdict

Tool A provides patient-facing retrospective monitoring of Atrial Fibrillation burden and lifestyle insights via a wearable, requiring a prior diagnosis. In contrast, Tool B is a physician-facing diagnostic aid that analyzes cardiac ultrasound images to measure Global Longitudinal Strain for assessing heart function. While both are FDA-cleared Cardiology AI tools, their distinct applications, data sources, and target users make them complementary rather than directly comparable.

Choose Atrial Fibrillation History Feature if…

Choose the Atrial Fibrillation History Feature if you are an individual already diagnosed with AFib and want to gain deeper, retrospective insights into your condition's burden over time. This tool is ideal for understanding how lifestyle factors like sleep and activity may influence your AFib, providing valuable data to share with your healthcare provider for informed discussions.

View Atrial Fibrillation History Feature →

Choose Strain AI if…

Choose Strain AI if you are a clinician performing cardiac ultrasounds and require an AI-powered solution for quantitative assessment of heart function. This tool is best suited for aiding in the diagnosis and monitoring of conditions such as heart failure and cardiotoxicity by providing objective Global Longitudinal Strain (GLS) measurements directly from ultrasound images.

View Strain AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Atrial Fibrillation History Feature Strain AI
Pricing Unknown Contact for pricing
Deployment Mobile App On-device AI, operates without internet connection.
BAA Available No AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA No AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Atrial Fibrillation History Feature

Tool A, integrated into the Apple Watch and iPhone, offers a highly intuitive and accessible user experience for individual patients managing their AFib. Its consumer-grade design prioritizes ease of use and data visualization for the end-user, including simple PDF export for physicians.

Clinical Value

Strain AI

Tool B provides real-time, quantitative diagnostic support by measuring Global Longitudinal Strain from ultrasound images, directly aiding physicians in assessing heart function and detecting critical conditions like heart failure. This offers a more immediate and objective impact on clinical decision-making compared to Tool A's retrospective patient insights.

Pricing & Value

Atrial Fibrillation History Feature

Tool A's AFib History feature is included as part of a compatible Apple Watch purchase, offering significant value without additional cost for the feature itself. Tool B requires direct contact for pricing, indicating a less transparent and potentially higher cost model for healthcare providers.

Enterprise Readiness

Strain AI

Tool B is explicitly designed for enterprise use within healthcare, evidenced by its HIPAA compliance, availability of a Business Associate Agreement (BAA), and on-device deployment for secure clinical environments. Tool A, while widely adopted by individuals, lacks the necessary enterprise-level compliance and integration features for direct use by healthcare organizations as a primary clinical tool.

Innovation

Strain AI

Tool B demonstrates strong innovation by applying AI directly to medical imaging for real-time, automated, and quantitative diagnostic measurements like Global Longitudinal Strain, streamlining complex clinical workflows. While Tool A innovates in democratizing health insights via consumer wearables, Tool B's innovation is more directly tied to advancing core diagnostic capabilities in a specialized medical field.

Support & Docs

Atrial Fibrillation History Feature

Tool A benefits from Apple's extensive consumer support ecosystem, including detailed online documentation, user guides, and readily accessible customer service for individual users. While Tool B, as a professional medical software, would have dedicated support, its documentation and assistance are typically less publicly accessible than Apple's broad consumer-facing resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Atrial Fibrillation History Feature Strain AI
Primary Function Provides diagnosed users with retrospective estimates of AFib burden and insights into how lifestyle factors may influence their condition. Analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions.
Specific Measurement/Analysis Retrospective AFib burden estimation (weekly percentage); visualization of lifestyle factors impacting AFib. Measures Global Longitudinal Strain (GLS).
Required Prior Diagnosis Requires a prior physician diagnosis of AFib for activation. Not specified
Intended Use Limitation Not intended for real-time AFib detection or continuous monitoring. Aids in assessing heart function and detecting conditions like heart failure and cardiotoxicity; delivers real-time, on-device AI insights.
Hardware/Software Requirements Compatible with Apple Watch Series 4 or later and iPhone 8 or later. Integrates with existing ultrasound devices.

Videos

Demos, reviews, and walkthroughs featuring Atrial Fibrillation History Feature and Strain AI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Apple's AFib History provides retrospective AFib burden estimates and lifestyle insights via a PDF export for physician review, requiring a prior AFib diagnosis. Exo's Strain AI integrates with existing ultrasound devices to provide real-time, on-device analysis of cardiac ultrasound images for Global Longitudinal Strain (GLS) measurements, aiding in immediate assessment of heart function.
The Apple AFib History feature allows users to export their data as a PDF for sharing with healthcare providers, but direct, automated EHR integration is not specified. Exo's Strain AI integrates with existing ultrasound devices to deliver its insights, but the specific depth of integration with broader EHR systems is not detailed.
Apple's AFib History provides retrospective estimates of AFib burden as a weekly percentage, with an average difference of 0.67% compared to a reference ECG patch in a clinical study. Exo's Strain AI provides quantitative Global Longitudinal Strain (GLS) measurements from cardiac ultrasound images, with a reported intraclass correlation coefficient (ICC) of 0.95 (0.91 u2013 0.97) and a root mean square difference (RMSD) of 2.76 (2.44 u2013 3.17) compared to reference data.
Apple's AFib History is primarily for Cardiology, Family Medicine, and Internal Medicine, focusing on tracking AFib burden and lifestyle factors in diagnosed patients. Exo's Strain AI is designed for Cardiology, Oncology, and Radiology, aiding in the assessment of heart function, detection of heart failure (CHF, HFpEF, HFrEF), and cardiotoxicity.
For Apple's AFib History, the learning curve for physicians primarily involves understanding how to interpret the exported PDF data and integrate these retrospective insights into patient discussions. Exo's Strain AI provides AI-driven insights without manual image interpretation, meaning the learning curve would focus on integrating the quantitative GLS measurements into diagnostic evaluations alongside existing ultrasound proficiency.
The Apple AFib History feature operates within the Apple ecosystem, with data residing in the user's Health app, which has its own security protocols. Exo's Strain AI operates as on-device AI without requiring an internet connection, which inherently enhances security by keeping sensitive patient data localized and reducing external network vulnerabilities.
Implementing Apple's AFib History feature across multiple sites primarily involves individual patient adoption of compatible Apple Watch and iPhone devices, with data sharing occurring on a patient-by-patient basis via PDF export. Exo's Strain AI can be scaled by integrating with existing ultrasound devices at various clinical sites, providing consistent, on-device AI analysis wherever compatible ultrasound equipment is available.

Backers

Who funded each tool's parent company.

Atrial Fibrillation History Feature

AI Tool Finder
AI-powered search. Results may not be comprehensive.